Windtree Therapeutics Inc (NASDAQ:WINT) has a beta value of 0.58 and has seen 1.47 million shares traded in the recent trading session. The company, currently valued at $2.62M, closed the recent trade at $0.31 per share which meant it lost -$0.01 on the day or -2.70% during that session. The WINT stock price is -4658.06% off its 52-week high price of $14.75 and 6.45% above the 52-week low of $0.29. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.6 million shares traded. The 3-month trading volume is 1.99 million shares.
The consensus among analysts is that Windtree Therapeutics Inc (WINT) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.92.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Over the past 30 days, the shares of Windtree Therapeutics Inc (NASDAQ:WINT) have changed -27.89%. Short interest in the company has seen 30861.0 shares shorted with days to cover at 0.01.
Windtree Therapeutics Inc (WINT) estimates and forecasts
Figures show that Windtree Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -90.52% over the past 6 months, with this year growth rate of 93.99%, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 66.05% over the past 5 years.
WINT Dividends
Windtree Therapeutics Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Insiders own 0.27% of the company shares, while shares held by institutions stand at 2.06% with a share float percentage of 2.07%. Investors are also buoyed by the number of investors in a company, with Windtree Therapeutics Inc having a total of 9.0 institutions that hold shares in the company.
